An Adaptive Intervention to Increase Engagement to Community-Based Care After an ED Admission
Launched by RHODE ISLAND HOSPITAL · Jul 22, 2025
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help young people who have recently been treated in the emergency room for suicidal thoughts or self-harming behavior. The goal is to create a short, family-focused program that encourages these youth to attend mental health care in their community after leaving the hospital. By improving understanding about mental health, helping families communicate better, and increasing follow-up care, the study hopes to reduce the chances that these young people will return to the emergency room for the same issues.
Youth between the ages of 8 and 17 who come to the emergency room because of suicidal or self-injurious behavior and live at home with a caregiver may be eligible to join. Participants and their families will take part in a flexible program that adjusts to their needs, aiming to make it easier to connect with ongoing mental health support. It’s important to know that youth with certain conditions, like psychosis or those currently involved with child protective services, may not be eligible. This study is currently recruiting, and families who join will help shape a program designed to better support young people after a crisis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Youth 8 to 17 years
- • Youth presenting to the ED with suicide and self-injurious behavior
- • Youth living at home with at least one legal guardian/caregiver
- Exclusion Criteria:
- • Youth presenting to the ED with psychosis, sexual assault, child abuse
- • Youth in police custody,
- • Youth with an active investigation with the department of child and youth services (DCYF)
- • Youth unable to assent due to severity of illness or developmental disabilities,
- • Youth who cannot communicate in English or Spanish,
- • Youth without a caregiver/legal guardian who can provide consent
About Rhode Island Hospital
Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported